>
Organization
Janssen Pharmaceuticals KK
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Janssen Pharmaceuticals KK

... and the rest of the world. Takeda Pharmaceutical Company Limited and Janssen Pharmaceutical K.K. co-promote VELCADE in Japan. VELCADE is approved in more than 90 ...
... and the rest of the world. Takeda Pharmaceutical Company Limited and Janssen Pharmaceutical K.K. co-promote VELCADE in Japan. VELCADE is approved in more than 90 ...
... and the rest of the world. Takeda Pharmaceutical Company Limited and Janssen Pharmaceutical K.K. co-promote VELCADE in Japan. About DACOGEN® (decitabine)6 DACOGEN® (decitabine), a DNA ...
... and the rest of the world. Takeda Pharmaceutical Company Limited and Janssen Pharmaceutical K.K. co-promote VELCADE in Japan. VELCADE is approved in more than 95 ...
... C virus (HCV) infection. Commenting on the approval, Bruce Goodwin, President, Janssen Pharmaceutical K.K., stated, "We submitted SOVRIAD for regulatory approval in February of this ...
... and the rest of the world. Takeda Pharmaceutical Company Limited and Janssen Pharmaceutical K.K. co-promote VELCADE (bortezomib) in Japan. Recent advances: VELCADE SUBCUTANEOUS and RETREATMENT ...
Subscribe now for full coverage on Janssen Pharmaceuticals KK
Start My Free Trial